Carlyle Group has made a significant investment in Baxter International"s Kidney Care segment, which will be rebranded as Vantive. The investment is part of a broader partnership with Atmas Health, a consortium of executives focused on acquiring and expanding healthcare companies. The transaction is expected to be completed in late 2024 or early 2025, pending regulatory approval. This investment reflects the growing importance of the healthcare sector, particularly in renal care, where there is a high demand for innovative solutions.
Fresenius Medical Care has achieved a milestone with over 14,000 patients in the United States using its NxStage systems for home hemodialysis treatment. This highlights the increasing acceptance and effectiveness of home dialysis solutions.
The company has also introduced the NxStage Versi HD, an enhanced home hemodialysis machine with GuideMe software to improve treatment processes and user experience. The rise in home hemodialysis patients demonstrates a trend towards patient-centered care and the demand for more convenient treatment options.
Researchers at UNC-Chapel Hill are developing membrane technology to reduce the size of dialysis equipment, aiming to create a portable dialysis machine as compact as a smartphone. This technology could provide continuous dialysis and improve the quality of life for individuals with chronic kidney disease. Such innovations are crucial in addressing the global demand for effective and convenient dialysis solutions.
The global hemodialysis and peritoneal dialysis market is projected to reach a valuation of USD 108.32 billion in 2024, with expectations to grow to USD 189.31 billion by 2034. North America is expected to maintain its dominant position in the market, driven by a high prevalence of chronic kidney disease and end-stage renal disease, advanced healthcare infrastructure, and favorable reimbursement policies.
Leading companies in the region, such as Fresenius Medical Care and Baxter, contribute to market growth through their commitment to innovative dialysis solutions.
The competitive landscape of the global hemodialysis and peritoneal dialysis market includes major players such as Fresenius Medical Care, DaVita Inc., Baxter International, and Medtronic. These companies continuously develop a wide range of products to meet the evolving market demands.